
Jason Michael Nolan
Examiner (ID: 10620)
| Most Active Art Unit | 1626 |
| Art Unit(s) | 1626, 1623 |
| Total Applications | 703 |
| Issued Applications | 439 |
| Pending Applications | 98 |
| Abandoned Applications | 189 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 8802437
[patent_doc_number] => 08440712
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-05-14
[patent_title] => 'Crystalline sodium atorvastatin'
[patent_app_type] => utility
[patent_app_number] => 13/112377
[patent_app_country] => US
[patent_app_date] => 2011-05-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 4051
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 97
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13112377
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/112377 | Crystalline sodium atorvastatin | May 19, 2011 | Issued |
Array
(
[id] => 6064420
[patent_doc_number] => 20110201651
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-08-18
[patent_title] => 'MITOTIC KINESIN INHIBITORS AND METHODS OF USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 13/093729
[patent_app_country] => US
[patent_app_date] => 2011-04-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 54863
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0201/20110201651.pdf
[firstpage_image] =>[orig_patent_app_number] => 13093729
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/093729 | Mitotic kinesin inhibitors and methods of use thereof | Apr 24, 2011 | Issued |
Array
(
[id] => 6167560
[patent_doc_number] => 20110195967
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-08-11
[patent_title] => '2-ARYL-ACETIC ACIDS, THEIR DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM'
[patent_app_type] => utility
[patent_app_number] => 13/092571
[patent_app_country] => US
[patent_app_date] => 2011-04-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 12097
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0195/20110195967.pdf
[firstpage_image] =>[orig_patent_app_number] => 13092571
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/092571 | 2-aryl-acetic acids, their derivatives and pharmaceutical compositions containing them | Apr 21, 2011 | Issued |
Array
(
[id] => 6064427
[patent_doc_number] => 20110201657
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-08-18
[patent_title] => 'AMIDE SUBSTITUTED INDAZOLE AND BENZOTRIAZOLE DERIVATIVES AS POLY(ADP-RIBOSE)POLYMERASE (PARP) INHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 13/091427
[patent_app_country] => US
[patent_app_date] => 2011-04-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 50774
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0201/20110201657.pdf
[firstpage_image] =>[orig_patent_app_number] => 13091427
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/091427 | AMIDE SUBSTITUTED INDAZOLE AND BENZOTRIAZOLE DERIVATIVES AS POLY(ADP-RIBOSE)POLYMERASE (PARP) INHIBITORS | Apr 20, 2011 | Abandoned |
Array
(
[id] => 8653125
[patent_doc_number] => 08372873
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-02-12
[patent_title] => 'Inhibitors of serine proteases'
[patent_app_type] => utility
[patent_app_number] => 13/074772
[patent_app_country] => US
[patent_app_date] => 2011-03-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 65014
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13074772
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/074772 | Inhibitors of serine proteases | Mar 28, 2011 | Issued |
Array
(
[id] => 7712531
[patent_doc_number] => 08093287
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-01-10
[patent_title] => 'Inhibitors of matrix metalloproteinases'
[patent_app_type] => utility
[patent_app_number] => 13/047605
[patent_app_country] => US
[patent_app_date] => 2011-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 14
[patent_no_of_words] => 55010
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/093/08093287.pdf
[firstpage_image] =>[orig_patent_app_number] => 13047605
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/047605 | Inhibitors of matrix metalloproteinases | Mar 13, 2011 | Issued |
Array
(
[id] => 8458252
[patent_doc_number] => 08293920
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-10-23
[patent_title] => 'Synthesis of enone intermediate'
[patent_app_type] => utility
[patent_app_number] => 13/043742
[patent_app_country] => US
[patent_app_date] => 2011-03-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 31637
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 5
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13043742
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/043742 | Synthesis of enone intermediate | Mar 8, 2011 | Issued |
Array
(
[id] => 8802432
[patent_doc_number] => 08440706
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-05-14
[patent_title] => 'Inhibitors of serine proteases'
[patent_app_type] => utility
[patent_app_number] => 13/036930
[patent_app_country] => US
[patent_app_date] => 2011-02-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 61415
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13036930
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/036930 | Inhibitors of serine proteases | Feb 27, 2011 | Issued |
Array
(
[id] => 8571813
[patent_doc_number] => 08338459
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-12-25
[patent_title] => 'Compounds, compositions and methods for stabilizing transthyretin and inhibiting transthyretin misfolding'
[patent_app_type] => utility
[patent_app_number] => 12/979733
[patent_app_country] => US
[patent_app_date] => 2010-12-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19407
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12979733
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/979733 | Compounds, compositions and methods for stabilizing transthyretin and inhibiting transthyretin misfolding | Dec 27, 2010 | Issued |
Array
(
[id] => 8270434
[patent_doc_number] => 08211935
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-07-03
[patent_title] => 'Heterocyclic derivatives for modulation of calcium channels'
[patent_app_type] => utility
[patent_app_number] => 12/971609
[patent_app_country] => US
[patent_app_date] => 2010-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25261
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12971609
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/971609 | Heterocyclic derivatives for modulation of calcium channels | Dec 16, 2010 | Issued |
Array
(
[id] => 9086431
[patent_doc_number] => 08557860
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-10-15
[patent_title] => 'Cyclopentane heptan(ENE)OIC acid, 2-heteroarylalkenyl derivatives as therapeutic agents'
[patent_app_type] => utility
[patent_app_number] => 12/967115
[patent_app_country] => US
[patent_app_date] => 2010-12-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 6373
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12967115
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/967115 | Cyclopentane heptan(ENE)OIC acid, 2-heteroarylalkenyl derivatives as therapeutic agents | Dec 13, 2010 | Issued |
Array
(
[id] => 6144530
[patent_doc_number] => 20110130349
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-06-02
[patent_title] => 'Compounds and Methods for Treating Toll-Like Receptor 2-Related Diseases and Conditions'
[patent_app_type] => utility
[patent_app_number] => 12/952713
[patent_app_country] => US
[patent_app_date] => 2010-11-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22221
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0130/20110130349.pdf
[firstpage_image] =>[orig_patent_app_number] => 12952713
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/952713 | Compounds and Methods for Treating Toll-Like Receptor 2-Related Diseases and Conditions | Nov 22, 2010 | Abandoned |
Array
(
[id] => 6039504
[patent_doc_number] => 20110092553
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-04-21
[patent_title] => 'Substituted Azole Derivatives, Compositions, and Methods of Use'
[patent_app_type] => utility
[patent_app_number] => 12/950967
[patent_app_country] => US
[patent_app_date] => 2010-11-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 88433
[patent_no_of_claims] => 53
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0092/20110092553.pdf
[firstpage_image] =>[orig_patent_app_number] => 12950967
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/950967 | Substituted Azole Derivatives, Compositions, and Methods of Use | Nov 18, 2010 | Abandoned |
Array
(
[id] => 6084135
[patent_doc_number] => 20110144123
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-06-16
[patent_title] => 'Thiazoles and Oxazoles Useful as Modulators of ATP-Binding Cassette Transporters'
[patent_app_type] => utility
[patent_app_number] => 12/913089
[patent_app_country] => US
[patent_app_date] => 2010-10-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20872
[patent_no_of_claims] => 52
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0144/20110144123.pdf
[firstpage_image] =>[orig_patent_app_number] => 12913089
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/913089 | Thiazoles and oxazoles useful as modulators of ATP-binding cassette transporters | Oct 26, 2010 | Issued |
Array
(
[id] => 4596593
[patent_doc_number] => 07982051
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-07-19
[patent_title] => 'Methods for preparing diazonamides'
[patent_app_type] => utility
[patent_app_number] => 12/896898
[patent_app_country] => US
[patent_app_date] => 2010-10-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 16717
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/982/07982051.pdf
[firstpage_image] =>[orig_patent_app_number] => 12896898
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/896898 | Methods for preparing diazonamides | Oct 2, 2010 | Issued |
Array
(
[id] => 6150918
[patent_doc_number] => 20110021972
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-01-27
[patent_title] => 'Composition and Device Structure For Iontophoresis'
[patent_app_type] => utility
[patent_app_number] => 12/895934
[patent_app_country] => US
[patent_app_date] => 2010-10-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 10321
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0021/20110021972.pdf
[firstpage_image] =>[orig_patent_app_number] => 12895934
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/895934 | Composition and device structure for iontophoresis | Sep 30, 2010 | Issued |
Array
(
[id] => 6150918
[patent_doc_number] => 20110021972
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-01-27
[patent_title] => 'Composition and Device Structure For Iontophoresis'
[patent_app_type] => utility
[patent_app_number] => 12/895934
[patent_app_country] => US
[patent_app_date] => 2010-10-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 10321
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0021/20110021972.pdf
[firstpage_image] =>[orig_patent_app_number] => 12895934
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/895934 | Composition and device structure for iontophoresis | Sep 30, 2010 | Issued |
Array
(
[id] => 8201225
[patent_doc_number] => 08188134
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-05-29
[patent_title] => 'Thiophene-carboxamides useful as inhibitors of protein kinases'
[patent_app_type] => utility
[patent_app_number] => 12/891973
[patent_app_country] => US
[patent_app_date] => 2010-09-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14698
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/188/08188134.pdf
[firstpage_image] =>[orig_patent_app_number] => 12891973
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/891973 | Thiophene-carboxamides useful as inhibitors of protein kinases | Sep 27, 2010 | Issued |
Array
(
[id] => 6353740
[patent_doc_number] => 20100331517
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-12-30
[patent_title] => 'POLYETHER CARBONATE POLYOLS MADE VIA DOUBLE METAL CYANDIE (DMC) CATALYSIS'
[patent_app_type] => utility
[patent_app_number] => 12/880231
[patent_app_country] => US
[patent_app_date] => 2010-09-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3554
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0331/20100331517.pdf
[firstpage_image] =>[orig_patent_app_number] => 12880231
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/880231 | Polyether carbonate polyols made via double metal cyanide (DMC) catalysis | Sep 12, 2010 | Issued |
Array
(
[id] => 6030869
[patent_doc_number] => 20110081312
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-04-07
[patent_title] => '3\'-[(2Z)-[1-(3,4-DIMETHYLPHENYL)-1,5-DIHYDRO-3-METHYL-5-OXO-4H-PYRAZOL-4-YLIDENE]HYDRAZINO]-2\'-HYDROXY-[1,1\'-BIPHENYL]-3-CARBOXYLIC ACID BIS-(MONOETHANOLAMINE)'
[patent_app_type] => utility
[patent_app_number] => 12/873565
[patent_app_country] => US
[patent_app_date] => 2010-09-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2556
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0081/20110081312.pdf
[firstpage_image] =>[orig_patent_app_number] => 12873565
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/873565 | 3′-[(2Z)-[1-(3,4-dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4H-pyrazol-4-ylidene]hydrazino]-2′-hydroxy-[1,1′-biphenyl]-3-carboxylic acid bis-(monoethanolamine) | Aug 31, 2010 | Issued |